028300.KQ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 09:30):

HLB Co., Ltd. manufactures pharmaceutical products, and builds ships. It manufactures and sells various types of lifeboats for marine plants, drill ships, and cruise vessels in South Korea...

Stats
Dzisiejszy wolumen	1.54M
Średni wolumen	2.96M
Kapitalizacja rynkowa	13 370.30B
EPS	KRW0 ( 2024-02-15 )
Następna data zysków	( KRW0 ) 2024-05-12
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW216.04 (0.21%)

Wolumen Korelacja

Długi: -0.33 (neutral)

Krótki: -0.80 (moderate negative)

Signal:(23.026) Neutral

HLB Co., Ltd. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

HLB Co., Ltd. Korelacja - Waluta/Towar

0.66
( moderate )

0.54
( weak )

0.08
( neutral )

0.73
( moderate )

-0.61
( weak negative )

HLB Co., Ltd. Finanse

Annual	2023
Przychody:	KRW42.90B
Zysk brutto:	KRW-6.01B (-14.01 %)
EPS:	KRW-1 559.61

FY	2023
Przychody:	KRW42.90B
Zysk brutto:	KRW-6.01B (-14.01 %)
EPS:	KRW-1 559.61

FY	2022
Przychody:	KRW179.71B
Zysk brutto:	KRW51.26B (28.52 %)
EPS:	KRW-694.20

Financial Reports:

No articles found.

HLB Co., Ltd.

HLB Co., Ltd. manufactures pharmaceutical products, and builds ships. It manufactures and sells various types of lifeboats for marine plants, drill ships, and cruise vessels in South Korea. The company offers conventional type lifeboats, free fall type lifeboats, and rescue boats. It also provides marine and yacht engines; hooks; RIB, patrol, fishing, aluminum, and leisure boats; fishery inspection ships; and safety goods, as well as lifeboat and davit inspection and repair services, service engineering training, and spare parts for lifeboats and davits. In addition, the company develops Riboseranib, a targeted anti-cancer agent; and Apilia that is used for the treatment for ovarian cancer. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.